Skip to content
healthcare.dev

Sertraline Hydrochloride

NDC 65862-013, Sertraline Hydrochloride, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
65862-013
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077206
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SERTRALINE HYDROCHLORIDE100 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Serotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]

Package NDCNDC-11Package
65862-013-0165862001301100 TABLET, FILM COATED in 1 BOTTLE (65862-013-01)
65862-013-0565862001305500 TABLET, FILM COATED in 1 BOTTLE (65862-013-05)
65862-013-25658620013252500 TABLET, FILM COATED in 1 BOTTLE (65862-013-25)
65862-013-306586200133030 TABLET, FILM COATED in 1 BOTTLE (65862-013-30)
65862-013-506586200135050 TABLET, FILM COATED in 1 BOTTLE (65862-013-50)
65862-013-606586200136060 TABLET, FILM COATED in 1 BOTTLE (65862-013-60)
65862-013-906586200139090 TABLET, FILM COATED in 1 BOTTLE (65862-013-90)
65862-013-99658620013991000 TABLET, FILM COATED in 1 BOTTLE (65862-013-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/39a85db1-9e59-4ab0-9e18-36757f019faa
  • NADAC price for package 65862001301

    GET /v1/drugs/nadac/65862001301
  • NADAC price for package 65862001305

    GET /v1/drugs/nadac/65862001305
  • NADAC price for package 65862001330

    GET /v1/drugs/nadac/65862001330

Use it

Look up 65862-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.